06/10/2022 8:25 AM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/23/2022 8:20 AM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/17/2022 8:40 PM | Nektar Therapeutics (Issuer) Zalevsky Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2022 8:38 PM | Nektar Therapeutics (Issuer) Wilson Mark Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2022 8:36 PM | Nektar Therapeutics (Issuer) Thomsen Jillian B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2022 8:35 PM | Nektar Therapeutics (Issuer) ROBIN HOWARD W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2022 8:33 PM | Nektar Therapeutics (Issuer) NORTHCOTT JOHN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2022 8:32 PM | Labrucherie Gil M (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2022 8:09 AM | Nektar Therapeutics (Filer)
| Form DEFA14A
| |
04/29/2022 8:05 AM | Nektar Therapeutics (Filer)
| Form DEF 14A
| |
|
04/25/2022 3:40 PM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/14/2022 3:44 PM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/17/2021 5:44 PM | Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2021 5:03 PM | CHESS ROBERT (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/31/2021 5:26 PM | GREER R SCOTT (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2021 6:01 PM | CHESS ROBERT (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2021 8:47 PM | Nektar Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/05/2021 3:21 PM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/22/2021 6:13 PM | CHESS ROBERT (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2021 3:05 PM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/19/2021 6:08 PM | Nektar Therapeutics (Issuer) Zalevsky Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2021 6:07 PM | Nektar Therapeutics (Issuer) Wilson Mark Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2021 6:06 PM | Nektar Therapeutics (Issuer) Thomsen Jillian B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2021 6:05 PM | Nektar Therapeutics (Issuer) ROBIN HOWARD W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2021 6:04 PM | Nektar Therapeutics (Issuer) NORTHCOTT JOHN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2021 6:04 PM | Labrucherie Gil M (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2021 5:05 PM | CHESS ROBERT (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/06/2021 3:21 PM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2021 11:27 AM | Nektar Therapeutics (Filer)
| Form DEF 14A
| |
04/16/2021 5:02 PM | CHESS ROBERT (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/25/2021 3:21 PM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/18/2021 6:07 PM | Nektar Therapeutics (Issuer) Zalevsky Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/18/2021 6:06 PM | Nektar Therapeutics (Issuer) Wilson Mark Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/18/2021 6:05 PM | Nektar Therapeutics (Issuer) Thomsen Jillian B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/18/2021 6:04 PM | Nektar Therapeutics (Issuer) ROBIN HOWARD W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/18/2021 6:03 PM | Nektar Therapeutics (Issuer) NORTHCOTT JOHN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/18/2021 6:03 PM | Labrucherie Gil M (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/17/2021 7:05 AM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/04/2021 7:44 PM | Nektar Therapeutics (Issuer) Wilson Mark Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2021 7:43 PM | Nektar Therapeutics (Issuer) ROBIN HOWARD W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2021 7:42 PM | Labrucherie Gil M (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2021 10:31 AM | Nektar Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
01/29/2021 5:10 PM | Nektar Therapeutics (Issuer) Thomsen Jillian B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2021 6:00 AM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2021 4:25 PM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2021 5:06 PM | Nektar Therapeutics (Issuer) WHITFIELD ROY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2020 5:53 PM | Nektar Therapeutics (Issuer) Zalevsky Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2020 5:52 PM | Nektar Therapeutics (Issuer) Wilson Mark Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2020 5:51 PM | Nektar Therapeutics (Issuer) Thomsen Jillian B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2020 5:50 PM | Nektar Therapeutics (Issuer) ROBIN HOWARD W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2020 5:49 PM | Nektar Therapeutics (Issuer) NORTHCOTT JOHN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2020 5:48 PM | Labrucherie Gil M (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2020 7:45 AM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/21/2020 3:31 PM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/17/2020 5:08 PM | Myriam Curet (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/25/2020 5:09 PM | Nektar Therapeutics (Issuer) Zalevsky Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2020 6:08 PM | Nektar Therapeutics (Issuer) Zalevsky Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2020 6:07 PM | Nektar Therapeutics (Issuer) Wilson Mark Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2020 6:05 PM | Nektar Therapeutics (Issuer) Thomsen Jillian B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2020 6:04 PM | Nektar Therapeutics (Issuer) ROBIN HOWARD W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2020 6:03 PM | Labrucherie Gil M (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/05/2020 7:43 PM | Nektar Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/05/2020 3:24 PM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2020 5:04 AM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2020 6:03 PM | Ajer Jeffrey Robert (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2020 7:16 PM | CHESS ROBERT (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2020 7:15 PM | Nektar Therapeutics (Issuer) WHITFIELD ROY A (Reporting)
| Form 4/A
| |
09/25/2020 7:14 PM | Lingnau Lutz (Reporting) Nektar Therapeutics (Issuer)
| Form 4/A
| |
09/25/2020 7:13 PM | GREER R SCOTT (Reporting) Nektar Therapeutics (Issuer)
| Form 4/A
| |
09/25/2020 7:13 PM | EASTHAM KARIN (Reporting) Nektar Therapeutics (Issuer)
| Form 4/A
| |
09/25/2020 7:12 PM | Myriam Curet (Reporting) Nektar Therapeutics (Issuer)
| Form 4/A
| |
09/25/2020 7:11 PM | CHESS ROBERT (Reporting) Nektar Therapeutics (Issuer)
| Form 4/A
| |
09/25/2020 7:10 PM | Ajer Jeffrey Robert (Reporting) Nektar Therapeutics (Issuer)
| Form 4/A
| |
09/24/2020 8:40 PM | Nektar Therapeutics (Issuer) WHITFIELD ROY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/24/2020 8:39 PM | Lingnau Lutz (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/24/2020 8:38 PM | GREER R SCOTT (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/24/2020 8:38 PM | EASTHAM KARIN (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/24/2020 8:37 PM | Myriam Curet (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/24/2020 8:36 PM | CHESS ROBERT (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/24/2020 8:35 PM | Ajer Jeffrey Robert (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/21/2020 7:59 PM | Labrucherie Gil M (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/21/2020 7:58 PM | Ajer Jeffrey Robert (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2020 7:19 PM | CHESS ROBERT (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2020 5:18 PM | Nektar Therapeutics (Issuer) WHITFIELD ROY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2020 5:41 PM | Nektar Therapeutics (Issuer) Zalevsky Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2020 5:40 PM | Nektar Therapeutics (Issuer) Wilson Mark Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2020 5:39 PM | Nektar Therapeutics (Issuer) Thomsen Jillian B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2020 5:38 PM | Nektar Therapeutics (Issuer) ROBIN HOWARD W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2020 5:37 PM | Labrucherie Gil M (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2020 3:10 PM | Nektar Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/06/2020 3:20 PM | Nektar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2020 6:06 PM | GREER R SCOTT (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2020 6:05 PM | CHESS ROBERT (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2020 5:33 PM | Nektar Therapeutics (Issuer) Zalevsky Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2020 5:32 PM | Nektar Therapeutics (Issuer) Wilson Mark Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2020 5:31 PM | Nektar Therapeutics (Issuer) Thomsen Jillian B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2020 5:30 PM | Nektar Therapeutics (Issuer) ROBIN HOWARD W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2020 5:29 PM | Labrucherie Gil M (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2020 8:26 PM | Nektar Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/17/2020 5:03 PM | CHESS ROBERT (Reporting) Nektar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |